Asia-Pacific Multiplex Assays Market – Industry Trends and Forecast to 2028

Market Analysis and Insights : Asia-Pacific Multiplex Assays Market

Data Bridge Market Research analyses that the Asia-Pacific multiplex assays market to be growing at a CAGR of 9.6% in the forecast period of 2021-2028.

Multiplex Assay is a form of immunoassay that determines many analytes in a single sample using magnetic or non-magnetic beads. A multiplex assay is identical to an ELISA, with the exception that beads are used to bind the capture antibody in multiplex assays. Multiplex assays are increasingly more common in research than in clinical settings due to their advantages.

Major factors that are expected to boost the growth of the multiplex assays market in the forecast period are the growing incidences of chronic illness mainly cancer and growing use of multiplex assays in companion diagnostics. Furthermore, the advantages of multiplex assays over singleplex and traditional assays, technological advancement, growing healthcare expenditure and rising awareness about the multifactorial nature various diseases and pathological conditions are further anticipated to propel the growth of the Multiplex Assays market. 

In addition, rise in the validation of biomarkers in molecular and protein diagnostics and need for high-throughput and automated systems will provide potential opportunities for the growth of the multiplex assays market in the coming years.

However, the high costs associated with equipment and lacks of skilled labor might further challenge the growth of the multiplex assays market in the near future.

This Asia-Pacific Multiplex Assays Market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Asia-Pacific Multiplex Assays Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Multiplex Assays Market Scope and Market Size

The multiplex assays market is segmented on the basis of product and services, type, technology, application and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of products and services, the multiplex assays market is segmented into reagents and consumables, instruments and accessories, and software and services.
• On the basis of type, the multiplex assays market is segmented into nucleic acid multiplex assays, protein multiplex assays, and cell-based multiplex assays. Protein multiplex assays have been further sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays have been further sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.
• On the basis of technology, the multiplex assays market is segmented into protein microarray, polymerase chain reaction, multiplex real-time PCR, flow cytometry, fluorescence detection, luminescence and others.
• On the basis of application, the multiplex assays market is segmented into clinical diagnostics, research and development. Clinical diagnostics have been further sub-segmented into cancer, autoimmune diseases, infectious diseases, nervous system disorders, infectious diseases, allergies, metabolism and endocrinology disorders, cardiovascular diseases, and others. Research and development has been further sub-segmented into drug discovery and development and biomarker discovery and validation.
• On the basis of end users, the multiplex assays market is segmented into hospital, clinical laboratories, pharmaceutical and biotechnology companies, research institutes and others.

 Asia-Pacific Multiplex Assays Market Country Level Analysis

The Asia-Pacific Multiplex Assays Market is analysed and market size insights and trends are provided by country, product and services, type, technology, application and end-users as referenced above.

The countries covered in the Asia-Pacific Multiplex Assays Market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China dominates the Asia-Pacific multiplex assays market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players, high healthcare expenditure and rising use of technological advance devices in hospitals in this region. India on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing awareness.

The country section of the Asia-Pacific multiplex assays market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific multiplex assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific multiplex assays market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Asia-Pacific Multiplex Assays Market Share Analysis

The Asia-Pacific multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Asia-Pacific multiplex assays market.

The major players covered in the Asia-Pacific multiplex assays market report are BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens AG, Hologic Inc., Luminex Corporation., MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc., Illumina, Inc., AGENA BIOSCIENCE, INC., Olink, Randox Laboratories Ltd., Bio-Techne., Agilent Technologies, Sysmex Corporation among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-27505